Tampa, FL, October 23, 2017/Globe Newswire – Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that Joshua (Josh) Mann recently joined the company as Vice President, Cancer Information...

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...

Last month a joint consensus statement developed by ASCO, the Association for Molecular Pathology (AMP), and the College of American Pathologists (CAP) on standardizing the interpretation and reporting of sequence variants in cancer was...

The American Society of Clinical Oncology (ASCO), the College of American Pathologists (CAP) and the American Society for Clinical Pathology (ASCP) have issued a joint guideline on HER2 testing for patients with gastroesophageal cancers. Read...

Download PDF of Recommendations The Washington Post (9/7, McGinley) highlights a report released by a “blue-ribbon panel” of “top cancer researchers and patient advocates” as part of the White House’s cancer moonshot. The report...

More interesting news around PD-L1 for use in Classical Hodgkin lymphoma with specific indications as below. Another increasingly common example of companion diagnostics and personalized immunotherapies. On May 17, 2016, the U.S. Food and Drug...